Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

3.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.2K
Composition of Blood Plasma01:24

Composition of Blood Plasma

8.5K
Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins,...
8.5K
Enlargement of the Plasma Membrane01:22

Enlargement of the Plasma Membrane

2.4K
Cell division and enlargement are processes that require precise control. The control ensures that cell division cannot proceed unless the cell has grown to a specific size. A spherical, dividing cell requires an approximately 1.6X increase in its surface area to double its volume. The secretory pathway also has a significant role in cell membrane enlargement. Secretory vesicles that bud off from the Golgi apparatus and later fuse with the plasma membrane during exocytosis are a major source of...
2.4K
Plasma Membrane in Bacteria and Archaea01:27

Plasma Membrane in Bacteria and Archaea

1.8K
The plasma membrane is an essential cellular structure responsible for maintaining cellular integrity and regulating the selective transport of molecules. While bacteria and archaea share the fundamental function of plasma membranes, their structural and molecular differences reflect adaptations to distinct ecological and physiological challenges.Bacterial Plasma MembranesBacterial plasma membranes are predominantly composed of phospholipids with fatty acid chains ester-linked to a glycerol...
1.8K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

8.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthobiologics at a Crossroads: From Biological Promise to Evidence-Based Orthopaedic Practice.

The Journal of bone and joint surgery. American volume·2026
Same author

Gathering Orthobiologic Real-World Evidence Using Registries and Biorepositories: Proceedings of the American Academy of Orthopaedic Surgeons-Biologic Association Symposium November, 2022: Erratum.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same author

CORR Insights®: Synthesis and Characterization of an Antimicrobial Honey-based Composite Bone Cement.

Clinical orthopaedics and related research·2026
Same author

Platelet Concentration Does Not Influence Clinical Efficacy and Retear Rates of Rotator Cuff Repair With Platelet-Rich Plasma: A Systematic Review and Meta-analysis With Meta-Regression.

The American journal of sports medicine·2026
Same author

Gathering Orthobiologic Real-word Evidence Using Registries and Biorepositories: Proceedings of the American Academy of Orthopaedic Surgeons-Biologic Association Symposium November, 2022.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same author

A standardized fluoroscopic method for profiling humeral rotational alignment during intramedullary nailing.

JSES reviews, reports, and techniques·2026

Related Experiment Video

Updated: Feb 2, 2026

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

5.0K

Platelet-Rich Plasma.

Adrian D K Le1, Lawrence Enweze1, Malcolm R DeBaun1

  • 1Department of Orthopedic Surgery, Stanford University, 450 Broadway Street, Redwood City, CA 94063, USA.

Clinics in Sports Medicine
|November 24, 2018
PubMed
Summary

Platelet-rich plasma (PRP) shows promise for musculoskeletal issues and is safe. However, its effectiveness varies, requiring more research due to inconsistent preparation methods impacting study results.

Keywords:
AugmentationOrthobiologicsOsteoarthritisPRPPlatelet-rich plasmaRegenerative medicineTendinopathy

More Related Videos

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
14:38

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

Published on: January 4, 2019

19.3K
Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
08:34

Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion

Published on: February 24, 2021

3.0K

Related Experiment Videos

Last Updated: Feb 2, 2026

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

5.0K
Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
14:38

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

Published on: January 4, 2019

19.3K
Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
08:34

Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion

Published on: February 24, 2021

3.0K

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Biologics

Background:

  • Platelet-rich plasma (PRP) is increasingly utilized for musculoskeletal conditions.
  • Clinical data suggest PRP is a safe therapeutic option.
  • Existing evidence on PRP efficacy presents considerable variability.

Purpose of the Study:

  • To evaluate the current evidence regarding the safety and efficacy of platelet-rich plasma (PRP) for musculoskeletal conditions.
  • To highlight the challenges in interpreting existing literature due to heterogeneity in PRP preparations.
  • To underscore the need for high-quality clinical trials to clarify PRP's therapeutic role.

Main Methods:

  • Review of existing clinical data and literature on PRP treatments for musculoskeletal maladies.
  • Analysis of the safety profile of PRP based on available clinical evidence.
  • Assessment of the variability and consistency of PRP efficacy across different indications.

Main Results:

  • PRP demonstrates a favorable safety profile in clinical applications.
  • Evidence for PRP efficacy is mixed and highly dependent on the specific musculoskeletal indication.
  • Significant heterogeneity exists in PRP preparation methods, complicating data interpretation.

Conclusions:

  • While safe, the variable efficacy of PRP necessitates cautious interpretation of current data.
  • Standardization of PRP preparation techniques is crucial for future research and clinical application.
  • High-quality, large-scale clinical trials are essential to establish definitive evidence for PRP's utility in musculoskeletal disorders.